Agenus(AGEN) - 2025 Q2 - Quarterly Results

FORM 8-K CURRENT REPORT This current report provides essential administrative and financial disclosures, including operational results and exhibit details, as mandated by SEC regulations Filing Information This section details the registrant's administrative information, including company name, jurisdiction, and stock exchange listing - Registrant is Agenus Inc., incorporated in Delaware[2] Registered Securities Information | Title of each class | Symbol(s) | Name of each exchange on which registered | | :------------------ | :-------- | :---------------------------------------- | | Common Stock, $0.01 par value per share | AGEN | The Nasdaq Global Market | - The registrant is not an emerging growth company[5] Item 2.02 Results of Operations and Financial Condition This section reports Agenus Inc.'s financial results for the quarter ended June 30, 2025, furnished via a press release - Agenus Inc. announced financial results for the quarter ended June 30, 2025, on August 11, 2025[6] - A press release, Exhibit 99.1, detailing financial results is furnished with this Form 8-K[6] - Information in Item 2.02 and Exhibit 99.1 is furnished, not filed, exempting it from Section 18 liabilities of the Securities Exchange Act of 1934[7] Item 9.01 Financial Statements and Exhibits This section identifies the exhibits furnished with the Form 8-K, specifically Exhibit 99.1, the Press Release - Exhibit 99.1 is the Press Release dated August 11, 2025[8] Signatures This section confirms the report's official signing by Christine M. Klaskin, VP, Finance, on August 11, 2025 - The report was signed on August 11, 2025[11] - Signed by Christine M. Klaskin, VP, Finance[11]